已收盘 02-06 16:00:00 美东时间
+0.485
+4.21%
今日重点评级关注:HC Wainwright & Co.:维持Enlivex Therapeutics"买入"评级,目标价从7美元升至13美元;BTIG:维持Oruka Therapeutics"买入"评级,目标价从63美元升至73美元
01-13 10:18
Keybanc analyst Eric Heath maintains Netskope (NASDAQ:NTSK) with a Overweight and lowers the price target from $28 to $24.
01-12 19:48
今日重点评级关注:杰富瑞:维持ImmunityBio Inc Ordinary Shares"买入"评级,目标价从8美元升至9美元;B. Riley证券:维持WAVE Life Sciences"买入"评级,目标价从19美元升至37美元
2025-12-15 15:30
Netskope shares are trading lower. The company reported Q3 financial results.
2025-12-12 22:00
Malcolm Ethridge picks Netskope as his final trade, while Bill Baruch chooses Coeur Mining. Jim Lebenthal and Joshua Brown choose Delta Air and Zoom as their picks respectively.
2025-12-12 20:43
Keybanc analyst Eric Heath maintains Netskope (NASDAQ:NTSK) with a Overweight and raises the price target from $27 to $28.
2025-12-12 20:28
Netskope (NASDAQ:NTSK) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.40) by 74.68 percent. The company reported quarterly sales of $184.200 million which beat the
2025-12-12 05:10
Companies Reporting Before The Bell • Hooker Furnishings (NASDAQ:HOFT) is estim...
2025-12-11 19:11
Netskope (NASDAQ:NTSK), a leader in modern security and networking for the cloud and AI era, today announced the general availability of enterprise security and AI integrations with Microsoft. The seamless integration of
2025-11-18 22:05
今日重点评级关注:Guggenheim:上调Neumora Therapeutics评级至"买入",目标价14美元;韦德布什:上调Fate Therapeutics评级至"跑赢大市",目标价从5美元升至7美元
2025-10-28 10:08